Skip to content

Impact of Eicosapentaenoic Acid on Metabolism and Blood Lipids

Impact of Eicosapentaenoic Acid on Metabolism and Blood Lipids

Scientists from Finland have studied the effects of eicosapentaenoic acid (EPA), an omega-3 fatty acid found in fish oil, on metabolism and blood lipid levels in healthy adults. Although EPA is already known to reduce the risk of cardiovascular diseases in people with high cholesterol or heart conditions, its effects on healthy individuals were not well understood.

Study of High-Dose Supplements

In this study, 38 volunteers were given very high doses of EPA supplements. Blood samples were collected before, during, and after the supplementation period to monitor how the body processed this fatty acid. The results showed significant variations among participants in how their bodies responded to EPA.

Professor Katarina Uni, one of the study’s lead authors, stated: “The results demonstrated the impact of EPA on all participants, but each sample was different within the group. In other words, each individual has a unique lipid fingerprint in their blood that persists despite taking supplements.”

Effective Absorption and Improvement in Lipid Levels

The researchers confirmed that EPA is effectively absorbed, leading to a sharp increase in its concentration in the blood, but levels dropped quickly once supplementation stopped. The most noticeable changes were among participants who started with lower EPA levels.

Additionally, EPA improved blood lipid profiles and reduced the tendency of lipoproteins to adhere to arterial walls, an important factor in preventing atherosclerosis.

Short-Term Effects and Future Research Prospects

Since the study was conducted over a short period, it did not measure long-term outcomes. However, the results indicated that EPA can alter blood lipid composition and affect early risk mechanisms for atherosclerosis even in healthy individuals.

Researcher Lauri Ikas commented: “The results highlight the importance of metabolism in preventing cardiovascular diseases. The effects of EPA were more varied among individuals than we expected, and we also showed that these effects dissipate quickly, which is good to know in case EPA has negative side effects.”

Conclusion

This study provides an in-depth look at how eicosapentaenoic acid affects the body, particularly concerning metabolism and blood lipid levels. Although the study did not assess long-term effects, the results suggest that EPA can have a positive impact even on healthy individuals. It remains to be seen how this knowledge can be used to improve strategies for preventing cardiovascular diseases in the future.